El-Galaly and colleagues [5] evaluated stage, extranodal involvement and prognostic indices in 443 newly diagnosed patients with DLBCL staged with PET-CT, treated with R-CHOP or R-CHOP-‘like’ chemotherapy. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.